Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 49

Results For "CENT"

4841 News Found

APHI welcomes CCI order on integrated healthcare delivery model
Healthcare | May 22, 2026

APHI welcomes CCI order on integrated healthcare delivery model

The ruling brings closure to a nearly decade-long investigation into hospital operations and healthcare delivery practices


IOLCP revenue rises 11.5% YoY to Rs. 2,319.1 crore in FY26
News | May 21, 2026

IOLCP revenue rises 11.5% YoY to Rs. 2,319.1 crore in FY26

Company’s EBITDA grew 29.3 per cent to Rs. 290.4 crore, while PAT rose 36.4 per cent to Rs. 137.7 crore


Apollo, Cloudnine merge maternity and fertility businesses in Rs. 1,550 crore deal
Hospitals | May 21, 2026

Apollo, Cloudnine merge maternity and fertility businesses in Rs. 1,550 crore deal

Combined platform with 55+ centres aims to expand integrated maternity, fertility, neonatal and paediatric care across India


Boehringer Ingelheim India signs MoUs with NIPER Ahmedabad and Hyderabad to expand research collaboration
R&D | May 21, 2026

Boehringer Ingelheim India signs MoUs with NIPER Ahmedabad and Hyderabad to expand research collaboration

This collaboration across the NIPER network- Raebareli, Hajipur, Ahmedabad and Hyderabad is strengthening translational research and opnMe access


India reaffirms commitment to global women and child health agenda at WHA 2026
Policy | May 21, 2026

India reaffirms commitment to global women and child health agenda at WHA 2026

Minister J.P. Nadda holds bilateral meeting with Helen Clark, Board Chair of the Partnership for Maternal, Newborn and Child Health in Geneva


Drug Safety Symposium 2026 to focus on real-world impact of pharmacovigilance
News | May 21, 2026

Drug Safety Symposium 2026 to focus on real-world impact of pharmacovigilance

The event is expected to attract more than 100 senior professionals from pharmaceutical companies, CROs, regulatory agencies, and technology organisations


Lilly's retatrutide delivers 30% weight loss in Phase 3 TRIUMPH-1 trial
News | May 21, 2026

Lilly's retatrutide delivers 30% weight loss in Phase 3 TRIUMPH-1 trial

All three dose levels, 4 mg, 9 mg and 12 mg, successfully met the primary and key secondary endpoints in 80 weeks


Amanta Healthcare reports 42% YoY growth in FY26 profit
News | May 20, 2026

Amanta Healthcare reports 42% YoY growth in FY26 profit

The company’s revenue stood at Rs. 287.68 crore, reflecting a 4.7 percent increase over Rs. 274.71 crore reported in FY25


360 ONE-backed Hearzap to acquire Amplifon India
Healthcare | May 20, 2026

360 ONE-backed Hearzap to acquire Amplifon India

Combined footprint expands to 420 hearing care centres across India